Springer Nature
Browse

MOESM8 of Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer

Download (46.14 kB)
figure
posted on 2019-10-30, 18:16 authored by Gareth Healey, Belen Pan-Castillo, Jezabel Garcia-Parra, Julia Davies, Shaun Roberts, Eilir Jones, Kalyan Dhar, Sarika Nandanan, Nasima Tofazzal, Luke Piggott, Richard Clarkson, Gillian Seaton, Asa Frostell, Tim Fagge, Colin McKee, Lavinia Margarit, R. Conlan, Deyarina Gonzalez
Additional file 8: Figure S6. RBGO2, RBGO3 and RBGO4 preferentially target endometrial cancer cells and increase drug sensitivity by up to 40-fold.

Funding

Welsh Government (A4B Programme)

History

Usage metrics

    Springer Nature

    Categories

    Keywords

    Endometrial cancerTherapeuticAntibody drug conjugatesRAGEHuman

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC